Inozyme Pharma Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2020
Period Ending	Jul '25 Jul 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2020
Market Capitalization	295	95	523	253	509	-	Upgrade
Market Cap Growth	-46.55%	-81.86%	106.42%	-50.21%	-	-	Upgrade
Enterprise Value	405	167	514	138	346	-	Upgrade
Last Close Price	19.80	12.44	86.66	61.63	237.35	-	Upgrade
Forward PE	-	2.16	-	-	-	-	Upgrade
PS Ratio	254.09	79.03	-	-	-	-	Upgrade
PB Ratio	3.71	1.22	1.18	0.60	1.90	-	Upgrade
P/TBV Ratio	3.71	1.22	1.18	0.60	1.90	-	Upgrade
EV/Sales Ratio	-	139.44	-	-	-	-	Upgrade
Debt / Equity Ratio	2.20	2.34	0.34	0.30	-	-	Upgrade
Asset Turnover	0.00	0.00	-	-	-	-	Upgrade
Inventory Turnover	3.18	5.87	-	-	-	-	Upgrade
Quick Ratio	1.03	1.03	1.33	2.33	18.34	1.57	Upgrade
Current Ratio	1.58	1.52	1.34	2.33	18.34	1.57	Upgrade
Return on Equity (ROE)	-206.14%	-192.35%	-32.68%	-13.66%	-14.19%	-8.66%	Upgrade
Return on Assets (ROA)	-28.51%	-26.97%	-8.27%	-5.76%	-6.46%	-2.97%	Upgrade
Return on Capital (ROIC)	-33.56%	-32.70%	-9.77%	-6.94%	-8.63%	-5.43%	Upgrade
Earnings Yield	-172.59%	-567.11%	-33.05%	-18.89%	-4.64%	-	Upgrade
FCF Yield	-65.41%	-235.46%	-41.52%	-89.35%	-26.67%	-	Upgrade
Buyback Yield / Dilution	-	-20.93%	-65.02%	-	-	-	Upgrade

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.